chr7-143935744-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004685.1(OR2F2):āc.512A>Gā(p.Asn171Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000824 in 1,614,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004685.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2F2 | NM_001004685.1 | c.512A>G | p.Asn171Ser | missense_variant | 1/1 | ENST00000408955.3 | NP_001004685.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2F2 | ENST00000408955.3 | c.512A>G | p.Asn171Ser | missense_variant | 1/1 | 6 | NM_001004685.1 | ENSP00000386222.2 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251484Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135914
GnomAD4 exome AF: 0.0000677 AC: 99AN: 1461892Hom.: 0 Cov.: 35 AF XY: 0.0000688 AC XY: 50AN XY: 727246
GnomAD4 genome AF: 0.000223 AC: 34AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.512A>G (p.N171S) alteration is located in exon 1 (coding exon 1) of the OR2F2 gene. This alteration results from a A to G substitution at nucleotide position 512, causing the asparagine (N) at amino acid position 171 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at